SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported) May 8, 2008
BARR PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
1-9860
|
|
42-1612474 |
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
of incorporation)
|
|
File Number)
|
|
Identification No.) |
|
|
|
225 Summit Avenue, Montvale, NJ
|
|
07645 |
(Address of principal executive offices)
|
|
(Zip code) |
(201) 930-3300
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On May 8, 2008, Barr Pharmaceuticals, Inc. (the Company) issued a press release announcing
results for the quarter ended March 31, 2008. A copy of the release is being furnished as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The
information furnished in this Item 2.02 and in Exhibit 99.1 below shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed
incorporated by reference in any filing with the Securities and Exchange Commission.
The Company will host a Conference Call at 8:30 AM Eastern time on Thursday, May 8, 2008 to
discuss earnings results for the quarter ended March 31, 2008. The number to call from within the
United States is: (800) 553-5275 and (612) 332-0345 Internationally. A replay of the conference
call will be available from 10:30 AM Eastern time on May 8, 2008 through 11:59 PM Eastern time May
22, 2008, and can be accessed by dialing (800) 475-6701 in the United States or (320) 365-3844
Internationally and using the access code 918406.
The conference call will also be webcast live on the Internet. Investors and other interested
parties may access the live webcast through the Investor Relations section, under Calendar of
Events, on Barrs website at www.barrlabs.com. Log on at least 15 minutes before the call begins
to register and download or install any necessary audio software.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
|
|
|
|
|
|
99.1
|
|
Barr Pharmaceuticals, Inc. May 8, 2008 earnings release. |